Company intelligence / Profile preview
Lagap SA
- Ownership
- Private
- Employees
- ~66
- Development stage
- Commercial
Overview
Lagap SA manufactures and markets around fifteen branded generic medicines from its production center in Bellinzona, Switzerland. The company focuses on affordable, high-quality products addressing key therapeutic areas such as gynaecology, paediatrics, rheumatology, pain management, procreation/sexology, and infectious diseases. It emphasizes sustainable local production using local active substances in most cases. Its portfolio includes both prescription drugs and over-the-counter products distributed across Europe, the Middle East, Africa, and emerging markets. No clinical trial results are published as it primarily produces generics.
- Therapeutic areas
- Men's HealthInfectious DiseasesOtherRheumatologyNeurologyWomen's Health
- Modalities
- Small molecules (capsules and tablets)
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Lagap SA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lagap SA.